Port of Spain, November 12, 2024: The Ministry of Health (MoH), via its Drug Inspectorate advises of the voluntary recall of Paracodeine Tablets, batch number KA23227, distributed in the Trinidad market.
The recall issued by Cipla Limited, the manufacturer of the product, is as a result of
an observed “Out of Specification” (OOS) result for the codeine content found during stability testing, conducted at the twelve (12) month interval under standard conditions.
Testing results conducted by Cipla Limited showed the codeine level slightly below the specification limit. The MOH has been liaising directly with the local distributors who in turn have been in contact with the retail sector to ensure affected batches are removed from circulation.
Out of an abundance of caution, the Ministry advises persons who may be in possession of the identified batch of Paracodeine Tablets to discontinue use immediately and to return the product to the place of purchase where possible.
Additional information can be obtained by contacting the Office of the Principal Pharmacist, Drug Inspectorate via email at druginspectorate@health.gov.tt or phone at 217-4664 ext. 13401.
The Ministry of Health will continue to monitor the situation and advise the population as necessary.
###
